
Company valuation, historical trends, and peer comparisons.
According to Erasca, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.88B. This represents a change of 59.18% compared to the average of 3.06B of the last 4 quarters.
The mean historical Enterprise Value of Erasca, Inc. over the last ten years is 1.11B. The current 4.88B Enterprise Value has changed 340.36% with respect to the historical average. Over the past ten years (40 quarters), ERAS's Enterprise Value was at its highest in in the June 2026 quarter at 5.71B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
1.11B
Median
1.03B
Minimum
282.68M
Maximum
2.05B
Discovering the peaks and valleys of Erasca, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 102.01%
Maximum Annual Enterprise Value = 2.05B
Minimum Annual Increase = -80.39%
Minimum Annual Enterprise Value = 282.68M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.03B | 80.04% |
| 2024 | 571.03M | 102.01% |
| 2023 | 282.68M | -4.76% |
| 2022 | 296.81M | -80.39% |
| 2021 | 1.51B | -24.72% |
| 2020 | 2.01B | -1.78% |
The current Enterprise Value of Erasca, Inc. (ERAS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
627.26M
5-year avg
738.50M
10-year avg
1.11B
Erasca, Inc.’s Enterprise Value is less than Revolution Medicines, Inc. (40.26B), greater than ArriVent BioPharma, Inc. (524.39M), greater than IDEAYA Biosciences, Inc. (2.76B), greater than ORIC Pharmaceuticals, Inc. (901.47M), greater than Tango Therapeutics, Inc. (3.42B), greater than Nuvation Bio Inc. (1.63B), greater than Kura Oncology, Inc. (834.50M), greater than Verastem, Inc. (815.12M), greater than Curis, Inc. (-3296530.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 40.26B | $40.44B | |
| 524.39M | $678.72M | |
| 2.76B | $3.01B | |
| 901.47M | $935.63M | |
| 3.42B | $3.74B | |
| 1.63B | $1.64B | |
| 834.50M | $880.29M | |
| 815.12M | $867.14M | |
| -3296530.00 | $1.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Erasca, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Erasca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Erasca, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Erasca, Inc. (ERAS)?
What is the 3-year average Enterprise Value for Erasca, Inc. (ERAS)?
What is the 5-year average Enterprise Value for Erasca, Inc. (ERAS)?
How does the current Enterprise Value for Erasca, Inc. (ERAS) compare to its historical average?